Denali Therapeutics (DNLI) Amortizatization of Intangibles (2024 - 2026)
Denali Therapeutics' (DNLI) quarterly Amortizatization of Intangibles came in at $916000.0 in Q1 2026, up 3.27% year-on-year from $887000.0 in Q1 2025, and little changed on a QoQ basis from $916000.0 in Q4 2025.
Denali Therapeutics (DNLI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has 3 years of Amortizatization of Intangibles data on file, last reported at $916000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 3.27% year-over-year to $916000.0 in Q1 2026; TTM through Mar 2026 was $3.6 million, a 74.28% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 203.17% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $916000.0, roughly flat from $916000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for DNLI reached as high as $916000.0 in Q4 2025 and fell as low as $400000.0 in Q3 2024.
- Historically, Amortizatization of Intangibles has averaged $816571.4 across 3 years, with a median of $900000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles soared 125.0% in 2025 and advanced 3.27% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $797000.0 in 2024, then gained by 14.93% to $916000.0 in 2025, then changed by 0.0% to $916000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $916000.0 in Q1 2026, $916000.0 in Q4 2025, and $900000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Denali Therapeutics | 4.33 Bn | 4.33 Bn | - | 916,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 916,000.00 |
| Mar 31, 2026 | 916,000.00 |
| Dec 31, 2025 | 916,000.00 |
| Dec 31, 2025 | 916,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 887,000.00 |
| Mar 31, 2025 | 887,000.00 |
| Dec 31, 2024 | 797,000.00 |
| Dec 31, 2024 | 797,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |